BPC157 (Bepecin, PL 14736), ein kleines, chemisch synthetisiertes Pentadecapeptid und eine partielle Sequenz des menschlichen Magensaftproteins BPC, das sich in klinischen Studien fr entzndliche Darmerkrankungen als sicher erwiesen hat und mglicherweise die Dehiszenz von Darmanastomosen heilen kann.
ClinicalPharmacy #AntifungalStewardship #Pharmacokinetics #InfectiousDiseases #MedicalEducation #PharmacyLeadership #DrJyothiJetti #PosaconazoleInsights #HealthcareCommunication To view or add a comment, sign in 371 followers
Common contraindications cited in the research-use community include: anyone with active or recent cancer (BPC-157 and TB-500 promote angiogenesis), people with Wilson's disease or other copper-metabolism disorders (GHK-Cu component), anyone pregnant or breastfeeding (no safety data), and athletes subject to WADA testing (BPC-157 and TB-500 are prohibited)
B12 may be tested alongside other metabolic markers if we suspect significant deficiency or insufficiency before designing your injection protocol
Where to buy BPC-157 Quality varies dramatically between vendors